We previously showed that G i2 proteins interfere with the transduction of CSF-1 receptor (CSF-1R) proliferation signals (Corre and Hermouet, 1995) . To identify CSF-1R pathways controlled by G i2 , we transfected v-fms, the oncogenic equivalent of CSF-1R, in NIH3T3 cells in which G i2 proteins were inactivated by stably expressing a dominant negative mutant form of the a subunit of G i2 (a i2 -G204A). Expression of a i2 -G204A resulted in decreased Src-kinase activity, delayed activation of p42 ERK-MAPK, decreased cyclin D1 expression and reduced proliferation in response to serum. In a i2 -G204A cells transfected with v-fms, Src-kinase activity remained de®cient but p42 MAPK activity and cyclin D1 expression were similar to those of vector/v-fms cells, suggesting that v-fms bypasses Src to activate the ERK-MAPK cascade. However, DNA synthesis and focus formation were inhibited by up to 80% in a i2 -G204A/vfms cells compared to vector/v-fms cells. We found that tyrosine phosphorylation of STAT3, also activated by CSF-1R/v-fms, was inhibited in a i2 -G204A/v-fms cells; in addition, expression of an 85 kDa, C-terminal truncated form of STAT3 (STAT3D) was constitutively increased. Both the inhibition of v-fms-induced STAT3 tyrosine phosphorylation and the increased expression of STAT3D were reproduced by transfecting a dominant negative mutant of Src. Last, we show that expression of STAT3D55C, a mutant form of STAT3 lacking the last 55 C-terminal amino acids, is sucient to inhibit DNA synthesis and v-fms-induced transformation in NIH3T3 cells. In summary, adequate regulation by G i2 proteins of the activity of both Src-kinase and STAT3 is required for optimal cell proliferation in response to CSF-1R/vfms.
Introduction
Cellular responses to most mitogenic stimuli include activation of the ERK-MAPK cascade. It is now well established that cell proliferation can be modulated by heterotrimeric G proteins and particularly by G i2 , presumably via the ERK-MAPK cascade (Hermouet et al., 1991; L'Allemain et al., 1991; Crespo et al., 1994; van Biesen et al., 1995) . This pathway is also activated by growth factor receptors with intrinsic tyrosinekinase activity and other receptors of the cytokine family with associated tyrosine-kinases. Activation of the ERK-MAPK cascade by receptor tyrosine-kinases involves tyrosine phosphorylation of adaptator molecules Shc, Grb2, stimulation of Ras GTP-binding by Sos or Vav, followed by successive activation of Rafkinase, mitogen and extracellular regulated kinase (MEK) and p42/p44 ERK-MAPK (Belka et al., 1995; Taniguchi, 1995) . In contrast, the mechanisms used by G protein-coupled receptors (GCRs) to activate p42/ p44 MAPK are less well understood. It is generally agreed that stimulation of G i -coupled receptors leads to tyrosine phosphorylation of Shc and Grb2, which then activate Sos, Ras, Raf-kinase, MEK and p42/p44 MAPK (Crespo et al., 1994; van Biesen et al., 1995; Gutkind, 1998a,b; Dhanasekaran et al., 1998) , but which eector(s) link G i proteins to tyrosine-phosphorylated Shc remains unclear. Activation of p42/p44 MAPK by G i proteins is often associated with activation of the tyrosine-kinase Src, and it was proposed that Src was part of the molecular link between G i proteins and Shc (Chen et al., 1994; Luttrell et al., 1996) . However, some authors assign GCRactivation of Src to G q , not G i , proteins (Wan et al., 1996; Kranenburg et al., 1997) and others suggest that other tyrosine-kinases (Btk, Itk, PYK-2, Syk) or phosphoinisotide 3' Kinase g (PI3Kg) link G i to Shc and the subsequent stimulation of the ERK-MAPK cascade and cell proliferation (Dikic et al., 1996; Wan et al., 1997; Bence et al., 1997) .
The aim of the present study was to determine at which level(s) G i2 -controlled pathways might interact with the signalling of hematopoietic cytokines. Indeed, using pertussis toxin (PT) to inactivate G i signalling, a number of studies have established that G i proteins regulate the transduction of proliferation signals of IL-3, GM-CSF, EPo and CSF-1 (He et al., 1988; Imamura and Kufe, 1988; Koyasu et al., 1989; Miller et al., 1991) . Upon CSF-1 binding, CSF-1 receptors (CSF-1R, or c-fms) activate ERK-MAPK (via the tyrosine phosphorylation of Shc and Grb2), JAK1/Tyk2 and STAT3, Src-kinases, PI3K and phosphotyrosinephosphatase 1C (PTP-1C or SHP-1) (Yeung et al., 1992; Courtneidge et al., 1993; Roussel, 1994; Novak et al., 1995) . We previously showed that G i2 proteins are responsible for the PT-sensitive regulation of CSF-1R proliferation signalling (Corre and Hermouet, 1995) . To investigate the regulation of CSF-1R signalling by G i2 proteins, we ®rst inactivated G i2 proteins in NIH3T3 cells by stably expressing a dominant negative mutant a subunit (a i2 -G204A) of G i2 (Hermouet et al., 1991) , then subjected the cells to transformation by v-fms, the oncogenic equivalent of CSF-1R, and studied the eect on three metabolic pathways potentially activated by both G i2 proteins and CSF-1R/v-fms: the ERK-MAPK cascade, Src-kinases and STAT3.
Results
Eect of a i2 -G204A on NIH3T3 cell proliferation and v-fms-induced transformation
The a i2 -G204A subunit can bind GTP, but remains blocked in its inactive, bg-bound conformation after GTP binding, eectively inactivating G i2 heterotrimers (Hermouet et al., 1991) . NIH3T3 cells stably transfected with vector alone or a i2 -G204A, then subjected to transfection with v-fms (called, respectively, vector/ v-fms and a i2 -G204A/v-fms cells) are described in Figure 1 . As expected, protein expression of a i2 was increased in a i2 -G204A/v-fms cells; v-fms expression was similar in vector/v-fms cells and a i2 -G204A/v-fms cells ( Figure 1a ). Protein expression of b and a q/11 subunits is shown in Figure 1b : expression of a q/11 was either unchanged or moderately increased, and expression of b subunits slightly increased, as described previously in cells expressing a i2 -G204A (Hermouet et al., 1991) .
Cell growth studies con®rmed that inactivation of G i2 results in reduced proliferation in response to serum (Table 1) : in the presence of 1% serum, [ 3 H]thymidine incorporation was inhibited by 64% in a i2 -G204A cells compared to vector cells. As expected, cell proliferation was stimulated by v-fms expression but both [ 3 H]thymidine incorporation and focus formation were inhibited, by up to 80%, in a i2 -G204A/v-fms cells compared to vector/v-fms cells (Table 1) . In other experiments, wild type NIH3T3 cells were co-transfected with either empty vector or a i2 -G204A and oncogenes v-fms and v-src (Table 1) : again, expression of a i2 -G204A signi®cantly inhibited vfms-induced focus formation, by an average of 38%, but had no eect on focus formation induced by v-src.
Eect of a i2 -G204A on Src-Kinase activity, Shc tyrosine phosphorylation, p42 MAPK activity and cyclin D1 expression in response to serum G i proteins presumably stimulate cell proliferation by regulating p42/p44 MAPK activity via Src-kinases and the phosphorylation of 52 kDa Shc on tyrosine residues. In NIH3T3 cells, Src and Fyn are the two most expressed kinases of the Src family. As shown in Figure 2a , expression of a i2 -G204A did not alter expression of Src and Fyn proteins. However, Srckinase activity measured 2 min after serum stimulation was inhibited by at least 50% in a i2 -G204A cells compared to vector cells (Figure 2b ). Expression of vfms did not restore Src-kinase activity, which remained lower by at least 50% in a i2 -G204A/v-fms cells compared to vector/v-fms cells (Figure 2b ). Expression of a i2 -G204A had no signi®cant eect on Fyn-kinase activity (Figure 2c ). Consistent with a de®cient activation of Src-kinase, tyrosine phosphorylation of 52 kDa Shc, measured 2 min after stimulation by serum, was decreased in a i2 -G204A cells (Figure 3) . With or without serum, expression of v-fms induced the tyrosine phosphorylation of 52 kDa Shc in vector/ v-fms cells. In a i2 -G204A/v-fms cells, tyrosine phosphorylation of Shc was low in the absence of serum, but relatively high in the presence of serum.
Activation of p42/p44 MAPK was then studied using the mobility shift assay (Figure 4 ), based on A B Figure 1 Expression of v-fms and a i2 mutants in transfected NIH3T3 cells. Membrane proteins of cells transfected with inactive a i2 -G204A or/and v-fms constructs were resolved by SDS/10% PAGE and subjected to immunoblotting with anti-vfms and anti-a i2 Ab (a) or anti-b and anti-a q/11 Ab. (b) Cells transfected with a i2 -Q205L, a constitutively activated form of Ga i2 (Hermouet et al., 1991) , used as a positive control in some experiments, are also shown (a) slower migration of phosphorylated (activated) p42MAPK (=pp42 MAPK). Protein expression of both p42 and p44 (not shown) MAPK was identical in all cell lines. In a i2 -G204A cells, serum-induced p42 MAPK activation was constantly delayed compared to vector cells (Figure 4a ). Used as a control, p42 MAPK activation was rapid (maximal at 2 min) in NIH3T3 cells expressing a i2 -Q205L, a constitutively activated form of a i2 (Figure 4a) . Unexpectedly, repeated experiments carried out at dierent times on v-fmsexpressing cells showed that despite the reduced proliferation of a i2 -G204A/v-fms cells, the kinetics of activation of p42 MAPK were identical in vector/v-fms cells and in a i2 -G204A/v-fms cells (Figure 4b ). Accordingly, expression of cyclin D1, which depends on p42/p44 MAPK activity (Lavoie et al., 1996) , was decreased in a i2 -G204A cells, but not in a i2 -G204A/vfms cells ( Figure 5 ). C-myc expression, which does not depend on p42/p44 MAPK, was also studied ( Figure   Figure 2 Src-and Fyn-kinase activity in a i2 -G204A and a i2 -G204A/v-fms cells. Cell lysates of subcon¯uent cells starved without serum, then stimulated with 5% serum for 2 min, were subjected to immunoprecipitation with anti-Src or anti-Fyn Ab and tyrosinekinase activity of immunoprecipitates (IP) was measured (see Materials and methods). Tyrosine-kinase activity of control IP (IP with irrelevant normal IgG) was always 40.05 u OD and was subtracted from tyrosine-kinase activity of Src and Fyn IP. In co-transfection experiments, wild type NIH3T3 cells were co-transfected with vector pZipNeoSV(X) or a i2 -G204A, v-fms or v-src cDNA constructs (see Materials and methods), then grown in DMEM and 10% CS, with a change of medium twice a week. Foci were scored after 21 days of incubation. Data are expressed as means+s.d. of 8 (v-fms) or 6 (vscr) co-transfections. *P50.05, Student's t-test Figure 3 Shc tyrosine phosphorylation in a i2 -G204A and a i2 -G204A/v-fms cells. Subcon¯uent cells starved for 16 h without serum were stimulated, or not, with 1% serum for 2 min, then lysed and cell lysates were subjected to immunoprecipitation with anti-Shc Ab or normal IgG. Shc IP were divided in two, submitted to SDS ± PAGE on two identical gels, transferred to PVDF membranes which were incubated with either antiphosphotyrosine (PY-20) Ab or anti-Shc Ab 5): basal expression and up-regulation of c-myc in response to serum were identical in vector cells and in a i2 -G204A cells. V-fms slightly increased c-myc levels in both vector/v-fms and a i2 -G204A/v-fms cells.
Eect of a i2 -G204A on the expression and phosphorylation status of STAT3 Several groups have reported that v-src and Src-kinase can activate STAT3 (Cao et al., 1996; Campbell et al., 1997; Chaturvedi et al., 1998) . In addition, Marrero et al. (1995) reported that activation of STAT3 can be induced or enhanced by GCRs, in particular by angiotensin II AT 1 receptor. Using polyclonal anti-STAT3 C-20 Ab (directed against the C-terminal part of STAT3), only one form of STAT3 (89 kDa) was detected in NIH3T3 cells and its expression was similar in all cell lines ( Figure 6 ). However, using anti-STAT3 mAb, three proteins of 89 kDa, 85 kDa and approximately 70 kDa were detected in NIH3T3 cell lysates: the less expressed 85 kDa and 70 kDa forms of STAT3 are presumably truncated in C-terminal since they are not recognized by C-20 Ab. Nuclear extracts were also studied (lower panel): although such nuclear protein preparations may also contain some cytosolic proteins, only 89 kDa and 85 kDa STAT3 were detected, suggesting that 70 kDa STAT3 is mainly cytosolic. Interestingly, C-terminal truncated STAT3 (STAT3D) proteins were expressed at higher levels in a i2 -G204A and a i2 -G204A/v-fms cells than in control cells, particularly in the absence of serum (second upper panel and lower panel).
Following serum stimulation, STAT3 (89 kDa) was weakly phosphorylated on tyrosine 705 in vector cells and in a i2 -G204A cells. More importantly, STAT3 was constitutively tyrosine-phosphorylated in vector/v-fms cells, but not in a i2 -G204A/v-fms cells. Most likely because of their low expression relative to 89 kDa STAT3, tyrosine phosphorylation of STAT3D forms was not detected. Western blotting with anti-phospho(Ser727)STAT3 Ab revealed that 89 kDa and 70 kDa STAT3 were the main forms phosphorylated on serine 727; serine 727 phosphorylation of 89 kDa STAT3 tended to be more important in cells expressing a i2 -G204A. Also, conservation of serine 727 in 70 kDa STAT3D indicates that 50 amino acids at most are missing in C-terminal; hence, the size of the protein can only be explained by an additional N-terminal truncation, strongly suggestive of proteolysis.
In a i2 -G204A/v-fms cells, p42 MAPK activity is maintained and activation of STAT3 de®cient, imply- Figure 4 p42 ERK-MAPK activation in a i2 -G204A and a i2 -G204A/v-fms cells. Subcon¯uent cells starved without serum were stimulated with 1% serum for the indicated times, then lysed and 50 mg of lysate proteins were separated by SDS ± PAGE. P42 MAPK and its phosphorylated (activated) counterpart, pp42 MAPK, were detected by immunoblotting with anti-ERK-MAPK Ab. (a) Cells transfected with vector alone or activated a i2 -Q205L (controls) or inactive a i2 -G204A (b) Vector/v-fms cells and a i2 -G204A/v-fms cells, stimulated with 1% serum for up to 2 h Figure 5 Cyclin D1 and c-myc expression in a i2 -G204A and a i2 -G204A/v-fms cells. Subcon¯uent cells starved overnight without serum were stimulated for the indicated times with 1% serum. (a) For cyclin D1 studies, cell lysates (100 mg) were subjected to 10% SDS ± PAGE and immunoblotting with anti-cyclin D1 Ab. (b and c) For c-myc studies, nuclear extracts (50 mg) were immunoprecipitated with anti-c-myc Ab or normal IgG, then IP were subjected to 10% SDS ± PAGE and immunoblotting with anti-cmyc Ab Figure 6 Expression and phosphorylation status of STAT3 in a i2 -G204A and a i2 -G204A/v-fms cells. Subcon¯uent cells starved overnight without serum were stimulated 1% serum, with lysed, and cell lysates (100 mg four upper panels) or nuclear extracts (30 mg, lower half-panel) were subjected to 8% SDS ± PAGE and immunoblotting with anti-phosphoSTAT3 (Tyr 705) Ab, antiphosphoSTAT3 (ser 727) Ab, anti-STAT3 mAb or anti-Cterminal STAT3 C-20 Ab. Experiments were repeated three times. STAT3 means 89 kDa STAT3 and STAT3D indicates Cterminal truncated forms of STAT3 ing that in NIH3T3 cells, tyrosine phosphorylation of STAT3 could not depend solely on ERK/MAPK. Indeed, experiments using PD 098059, a speci®c inhibitor of MEK-1 (Alessi et al., 1995) , showed that treatment of vector and vector/v-fms cells with 20 mM PD 098059 was sucient to block p42 MAPK activation and [ 3 H]thymidine incorporation but did not aect tyrosine and serine phosphorylation of STAT3 (not shown). We then investigated whether or not the abnormal expression and function of STAT3 observed in NIH3T3 cells expressing a i2 -G204A resulted from de®cient Src activity. Src function was speci®cally altered by transient expression of Src (dn), a dominant negative mutant of Src, c-Src or v-Src, the oncogenic, constitutively activated form of Src. As shown in Figure 7 , v-fms, c-Src and v-Src all stimulated the tyrosine phosphorylation of STAT3 (Figure 7a,c) ; in contrast, expression of Src (dn) inhibited v-fmsinduced tyrosine phosphorylation of STAT3 (Figure  7b,c) . Moreoever, expression of Src (dn) slightly increased the level of expression of 85 kDa STAT3D (Figure 7c ).
Eect of STAT3D55C on STAT3 activation and NIH3T3 cell proliferation and transformation by v-fms STAT3D55C, a 85 kDa form of STAT3 lacking the last 55 C-terminal amino acids, acts as a dominant negative mutant for the transcription of genes regulated by STAT3 (Wen et al., 1995; Kim and Baumann, 1997; Wang et al., 1999) . As STAT3 has been shown to regulate mitogenesis or/and prevention of cell apoptosis in various cell types (Fukada et al., 1996; Chaturvedi et al., 1998) and 85 kDa STAT3D proteins are overexpressed in a i2 -G204A and a i2 -G204A/v-fms cells, we investigated whether excessive STAT3D expression inhibits NIH3T3 cell proliferation. Cells stably transfected with STAT3D55C cDNA showed increased expression of 85 kDa STAT3D (Figure 8 ), but also, as observed previously (Kim and Baumann, 1997) , a slightly decreased expression of 89 kDa STAT3. Consistently, levels of both serine-and tyrosine-phosphorylated 89 kDa STAT3 in response to serum were low in STAT3D55C cells. In the presence of serum, [ 3 H]thymidine incorporation was inhibited by 550% in STAT3D55C cells, compared to control cells, and, when subjected to transformation by v-fms, STAT3D55C cells formed less foci than control cells (Table 2 ). For each transfection the amount of DNA was bought to 20 mg/ ml by including empty vector DNA (Vec). After 24 h recovery, cells were incubated for additional 6 h in the absence of serum, then lysed. Lysates (30 mg) were analysed by Western blotting for immunodetectable phosphotyrosine-STAT3 (PY-STAT3) and STAT3. (c) Cells stably transfected with empty vector, v-fms or v-Src subjected to transient transfection with Src (dn) and grown for 48 h with 10% serum, were starved overnight then stimulated with 1% serum for 15 min and lysed. Cell lysates (100 mg) were subjected to immunoblotting with anti-phosphoSTAT3 (Tyr 705) Ab, then anti-STAT3 mAb 
Discussion
The present study shows in vivo that active G i2 proteins are necessary for optimal signalling of tyrosine-kinase receptors, including oncogenic v-fms, and provides evidence that G i2 proteins modulate tyrosine-kinase receptor signalling by regulating metabolic pathways other than the ERK-MAPK cascade, i.e. Src-kinase and STAT3. It also shows that G i2 proteins and Srckinase regulate the expression of 85 kDa, C-terminal truncated STAT3, and that one consequence of 85 kDa STAT3 expression is the negative regulation of cell proliferation.
Our study demonstrates in intact cells that G i2 function is required for optimal Src-kinase activity, Shc tyrosine phosphorylation and subsequent activation of ERK-MAPK and cyclin D1 expression in response to serum. V-fms also stimulates the ERK-MAPK pathway, as shown by the increase in Shc tyrosine phosphorylation and cyclin D1 levels. In NIH3T3 cells, ERK-MAPK activity is necessary for cell proliferation induced by serum (Pages et al., 1993) ; our experiments with MEK-1 inhibitor PD 098059 show that ERK-MAPK activity is also necessary for vfms-induced cell proliferation. Thus, it was unexpected that the inhibition of v-fms-induced cell proliferation and transformation observed in cells with inactive G i2 proteins was not explained by reduced ERK-MAPK activity, particularly since Src-kinase activity was impaired. This suggests that v-fms compensates for de®cient G i2 function for p42 MAPK activation, possibly via the tyrosine phosphorylation of Shc, but does not compensate for Src-kinase activation and cell proliferation.
As both bg and a q/11 were shown to be able to activate Src-kinase (Chen et al., 1994; Wan et al., 1996; Luttrell et al., 1996) , the observation that expression of these subunits was not decreased in cells expressing a i2 -G204A (Figure 1b) rules out that the reduced Srckinase activity of these cells is the consequence of a de®cit of Ga q or bg proteins. Hence, our study provides the ®rst evidence that functional G i2 proteins are necessary for optimal Src-kinase activation by serum or tyrosine-kinase receptors. This ®nding is consistent with previous reports that, like G i2 , Src-kinase is required for the transduction of CSF-1R proliferation signals (Roussel, 1994; Roche et al., 1995a,b) . Hence, a constantly depressed Src-kinase alone could explain the impaired proliferation and transformation of a i2 -G204A cells in response to v-fms. The regulation of Src-kinase activity by G i2 proteins is speci®c: Fyn expression and activity were not altered in cells expressing a i2 -G204A, indicating that Fyn did not compensate for Src in signalling leading to cell proliferation. Indeed, the role played by Src in the regulation of cell proliferation is thought to be essential: it was reported that Src stimulates JAK1 and STAT3 (Cao et al., 1996 ; Campbell et al., 1997; Chaturvedi et al., 1998) and also that impaired ®broblast proliferation related to de®cient Src-kinase activity could be rescued by c-myc (Roche et al., 1995b) . In our model, we found no evidence linking Src activity and c-myc expression; v-fms expression increased c-myc levels to similar levels in cells with active or inactive G i2 proteins (i.e., intact or de®cient Src-kinase activity). In contrast, de®cient G i2 and Srckinase function was associated with severely impaired activation of STAT3.
STAT3 is activated by phosphorylation on tyrosine residues by a number of cytokines (including IL-3, IL-6, CSF-1) and STAT3 activation by IL-3 or IL-6 requires Src-kinase (Chaturvedi et al., 1998; Wang et al., 1999) . Similarly, we found that v-fms induces constitutive tyrosine phosphorylation of STAT3 in cells with active G i2 and Src proteins, but not in cells with de®cient G i2 and/or Src proteins, indicating that v-fms requires Src to activate STAT3 and that Src-mediated activation of STAT3 may be the decisive event regulated by G i2 proteins in the transduction of CSF-1R signalling. However, although Src was reported to interact directly with STAT3 in several cell types (Cao et al., 1996; Campbell et al., 1997; Chaturvedi et al., 1998) , in NIH3T3 cells Src and STAT3 could not be co-precipitated with anti-Src or anti-STAT3 antibodies (not shown). In our model, inactivation of G i2 proteins and/or Src-kinase was accompanied by increased expression of truncated forms of STAT3: 85 kDa STAT3D was constitutively expressed, whereas 70 kDa STAT3D, a cytosolic, C-and N-terminal truncated, unconstantly expressed form, appears to be the result of proteolysis. As C-terminal truncated STAT3 forms, notably 85 kDa STAT3D55C, are thought to be inactive, dominant negative forms of STAT3 that can form complexes with 89 kDa STAT3 but cannot initiate gene transcription (Wen et al., 1995; Kim and Baumann, 1997; Wang et al., 1999) , the observation that a moderate overexpression of STAT3D55C inhibits proliferation and v-fms-induced transformation demonstrates that STAT3 is critical for the transduction of v-fms (CSF-1R) proliferation signals. Hence, the excess of 85 kDa STAT3 in cells with de®cient G i2 and/or Src proteins suggests that, via Src-kinase, G i2 proteins can regulate the initiation of STAT3-induced transcription in two ways: by controlling STAT3 activation, and by altering the expression of 85 kDa STAT3.
Last, as a signalling of hematopoietic cytokines frequently involves Src and sometimes STAT3 (IL-3, IL-6), G i2 proteins could regulate signal transduction of cytokines other than CSF-1. Indeed, several studies have shown that ligands of receptors directly coupled to heterotrimeric G proteins, such as adrenergic agonists or chemokines, can modulate cytokine-induced proliferation and/or dierentiation of hematopoietic progenitors (Maestroni and Conti, 1994; Mayani et al., 1995) . In particular, we recently described the requirement of a functional IL-8/G i2 pathway for progenitor cell proliferation in response to a combination of cytokines that included IL-3 and IL-6 (Corre et al., 1999) . These observations suggest that an adequate G i2 -coupled receptor-mediated activation of Src-kinase, and subsequently of STAT3 and the ERK-MAPK pathway, may be a pre-requisite for hematopoietic cell proliferation in response to cytokines.
Materials and methods

Reagents and antibodies
Anity-puri®ed antisera AS-7 (Ga i2 ), QL (Ga q/11 ) and SW (Gb) were gifts from Dr Allen Spiegel (NIDDK, NIH, Bethesda, MD, USA). Anti-v-fms antiserum was provided by 
Cell transfections
Murine NIH3T3 ®broblasts were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% calf serum (CS). The inactive, dominant negative mutant form of the a subunit of G i2 (a i2 -G204A) and empty vector (pZipNeoSV(X)) were stably transfected in NIH3T3 cells as described (Hermouet et al., 1991) , then pools of transfected cells were subjected to a second transfection with 0. (Hermouet et al., 1991) . Experiments were carried out in triplicate and repeated at least three times.
Transformation assays In a ®rst series of experiments, NIH3T3 cells transfected with vector alone or vector+v-fms and cells expressing a i2 -G204A or a i2 -G204A+v-fms were assessed for focus formation. 3610 4 cells/ml were plated in triplicate in 60 mm dishes in 5 ml DMEM plus 10% CS and incubated at 378C for 21 days. Medium was changed twice a week and foci were scored at day 21. In other series of experiments, focus formation was assessed using simultaneous co-transfections, by the calcium phosphate precipitation technique, of wild type NIH3T3 cells with 4 mg plasmid DNA/plate of either pZipNeoSV(X) or a i2 -G204A constructs and 0.2 mg/plage of either v-fms or v-src DNA. NIH3T3 cells stably expressing STAT3D55C were also transfected with v-fms DNA (0.2 mg per plate), grown in DMEM and 10% CS with a change of medium twice a week and foci were scored at day 21.
Immunoblotting studies After two washes in PBS pH 7.5, cell pellets were frozen at 7708C until cell fraction preparation. Membranes and whole cell lysates were prepared as previously described (Corre and Hermouet, 1995) . Nuclear extracts were prepared as follows: after washing with PBS, cell pellets (10 6 cells) were resuspended in 400 ml cold 10 mM HEPES buer (pH 7.9) containing 10 mM KCl, 0.1 mM EDTA (Ethylene Diamine Tetraacetic acid), 0.1 mM EGTA (Ethylenediamine(oxyethylenenitrilo) Tetraacetic acid), 1 mM dithiothreitol (DTT) and 0.5 mM phenylmethylsulfonyl¯uoride (PMSF); after a 15 min incubation on ice, 25 ml of a 10% Nonidet P-40 (NP-40) solution were added and tubes were brie¯y centrifuged. Nuclear pellets were resuspended in 50 ml cold 20 mM HEPES buer (pH 7.9) containing 0.4 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 1 mM PMSF, incubated for 15 min on ice on a shaking platform, then centrifuged in a microfuge at 48C and supernatants (nuclear extracts) were kept at 7808C until use. Protein concentration was determined by the BCA method (Pierce) with BSA used as a standard. Proteins were resolved on SDS-polyacrylamide gels, transferred onto polyvinylidene di¯uoride (PVDF) membranes (Millipore) and immunoblotted with the appropriate antibody. Detection of the antibody-antigen complex was by enhanced chemiluminescence procedure (ECL kit, Boehringer-Mannheim).
p42/p44 MAPK studies MAPK activation was studied using a mobility shift assay. Subcon¯uent cells cultured in 60 mm dishes were starved for 16 h without serum, then stimulated for various times with 1% serum. After two washes with ice-cold PBS, cells were lysed with 100 ml of NP-40 lysis buer (10 mM Tris pH 7.1, 0.5% NP-40, 50 mM NaCl, 50 mM NaF, 30 mM Na 4 P 2 O 7 , 100 mM Na 3 VO 4 , 5 mM ZnCl 2 , 1 mM PMSF. Fifty mg lysate proteins were loaded on a 10% SDS-polyacrylamide gel (ratio of acrylamide/bis-acrylamide in 30% stock solution: 29.7/0.3) and electrophoresis performed for 24 h at 90 V constant. p42 and p44 MAPK and their phosphorylated counterparts (pp42 and pp44) were detected by immunoblotting. Only p42 and pp42, considered representative of p42/p44 MAPK activation, are shown.
Src-and Fyn-kinase studies Activity of Src and Fyn tyrosine-kinases was studied using a photometric enzyme immunoassay (Tyrosine-Kinase assay kit, BoehringerMannheim). Cells grown to subcon¯uence in DMEM plus 10% CS then starved without serum for 16 h, were stimulated with 5% CS for 2 min, then washed and scraped in ice-cold PBS. After centrifugation, cell pellets were resuspended in 1 ml of lysis buer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 0.25% sodium deoxycholate, 0.1% NP-40, 1 mM Na 3 VO 4 , 1 mM sodium¯uoride (NaF), 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM PMSF), incubated on ice for 10 min and centrifuged. Lysates (1 mg) were pre-cleared with 50 ml of 50% Protein ASepharose beads, then incubated with 1 mg of M327 antiSrc or anti-Fyn Ab for 3 h at 48C under rotative agitation and 50 ml of 50% Protein A-Sepharose beads were added. After 1 h of incubation at 48C, immunoprecipitates (IP) were collected by centrifugation. For evaluation of Src and Fyn kinase expression, IP were washed ®ve times with lysis buer, eluted by boiling in 26Laemmli sample buer and analysed by 8 ± 12% SDS ± PAGE and immunoblotting with anti-Src or anti-Fyn Ab. For tyrosine-kinase assays, Src and Fyn IP were washed three times with lysis buer, once with low salt buer (100 mM NaCl, 10 mM Tris-HCl pH 7.4, 10 mg/ml aprotinin, 10 mg/ml leupeptin) and tyrosine-kinase assays were performed according to the manufacturer's instructions: brie¯y, IP were incubated with EGPWLEEEEEAYGWMDF-amide, a speci®c tyrosinekinase substrate, in kinase buer (10 mM Tris-HCl pH 7.4, 1 mM DTT, 1 mM Na 3 VO 4 ) for 40 min at 308C, then the reaction was stopped by addition of the speci®c tyrosine-kinase inhibitor piceatannol. Tyrosine phosphorylation of the Src-kinase substrate was evaluated by ELISA with anti-phosphotyrosine PY-20 Ab.
Shc, cyclin D1, c-myc and STAT3 studies Semi-con¯uent cells were starved overnight without serum, then 1% CS was added for variable periods of time. Cell stimulation was stopped by washing and scraping cells in ice-cold PBS. Cell pellets were resuspended in appropriate buer to prepare either whole cell lysates (Shc, cyclin D1, STAT3) or nuclear extracts (c-myc, STAT3). Whole cell lysates (100 mg) and nuclear extracts (30 or 50 mg) were then subjected to SDS ± PAGE and immunoblotting (cyclin D1, STAT3) or to immunoprecipitation followed by SDS ± PAGE and immunoblotting (Shc, c-myc).
Note added in proof While this work was being reviewed, Luttrell et al. reported in Science (283: 655 ± 660, 1999 ) the agonist-promoted formation of a protein complex containing the G i2 -coupled b2-adrenergic receptor, b-arrestin-1 and Src; in this report, they proposed that b-arrestin binding to Src results in Src recruitment to the membrane and kinase activation, and that b-arrestin-`densensitized' G i2 -coupled receptors serve as scaolds for Src-dependent activation of Ras/Erk pathways.
